Detalhe da pesquisa
1.
Functional reprogramming of regulatory T cells in the absence of Foxp3.
Nat Immunol
; 20(9): 1208-1219, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31384057
2.
Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study.
J Allergy Clin Immunol
; 153(5): 1423-1431.e2, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290608
3.
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.
Lancet
; 402(10396): 129-140, 2023 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352885
4.
Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function.
Blood
; 137(18): 2450-2462, 2021 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512449
5.
Preemptive hematopoietic cell transplantation for asymptomatic patients with X-linked lymphoproliferative syndrome type 1.
Clin Immunol
; 237: 108993, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35367395
6.
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.
Blood
; 135(23): 2094-2105, 2020 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32268350
7.
Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation.
J Clin Immunol
; 41(1): 89-98, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33067658
8.
Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
J Clin Immunol
; 40(8): 1211-1213, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32860171
9.
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.
Blood
; 132(17): 1737-1749, 2018 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30154114
10.
Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
J Clin Immunol
; 39(7): 653-667, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31376032
11.
Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH.
Blood
; 129(22): 2993-2999, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28270454
12.
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study.
J Allergy Clin Immunol
; 141(3): 1036-1049.e5, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29241729
13.
Post-Transplant CD34+ Selected Stem Cell "Boost" for Mixed Chimerism after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Children and Young Adults with Primary Immune Deficiencies.
Biol Blood Marrow Transplant
; 24(7): 1527-1529, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29555312
14.
Correction to: Use of Genetic Testing for Primary Immunodeficiency Patients.
J Clin Immunol
; 38(4): 540-541, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29781065
15.
Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.
Blood
; 127(1): 17-28, 2016 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26504182
16.
Incidence and Outcomes of Central Nervous System Hemophagocytic Lymphohistiocytosis Relapse after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 23(5): 857-860, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28219834
17.
Persistent Enteropathy in a Toddler with a Novel FOXP3 Mutation and Normal FOXP3 Protein Expression.
J Pediatr
; 186: 183-185, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28457527
18.
IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndrome.
J Allergy Clin Immunol
; 135(3): 762-70, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25174872
19.
Outcomes of donor lymphocyte infusion for treatment of mixed donor chimerism after a reduced-intensity preparative regimen for pediatric patients with nonmalignant diseases.
Biol Blood Marrow Transplant
; 21(2): 288-92, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25464116
20.
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen.
Biol Blood Marrow Transplant
; 21(8): 1460-70, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25865646